Browsing byAuthorChellappan, DK

Jump to a point in the index:
Showing results 1 to 20 of 192  next >
Issue DateTitleAuthor(s)
2022-01-10Studies on Synthesis and Characterization of Fe3O4@SiO2@Ru Hybrid Magnetic Composites for Reusable Photocatalytic ApplicationKumar, AP; Bilehal, D; Desalegn, T; Kumar, S; Ahmed, F; Murthy, HCA; Kumar, D; Gupta, G; Chellappan, DK; Singh, SK; Dua, K; Lee, Y-I
2021-12-16Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions.Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S
2021-12Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapyChan, Y; Ng, SW; Tan, JZX; Gupta, G; Negi, P; Thangavelu, L; Balusamy, SR; Perumalsamy, H; Yap, WH; Singh, SK; Caruso, V; Dua, K; Chellappan, DK
2021-12Microfluidic chips: recent advances, critical strategies in design, applications and future perspectivesPattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V
2021-12Development and validation of RP-HPLC based bioanalytical method for simultaneous estimation of curcumin and quercetin in rat's plasmaWadhwa, S; Kumar, B; Gulati, M; Gupta, S; Chaitanya, MVNL; Kumar, D; Jha, NK; Gupta, G; Prasher, P; Chellappan, DK; Dua, K; Singh, SK
2021-11Potentialities of aptasensors in cancer diagnosisSharma, A; Dulta, K; Nagraik, R; Dua, K; Singh, SK; Chellappan, DK; Kumar, D; Shin, D-S
2021-11Bacterial biofilms associated skin disorders: Pathogenesis, advanced pharmacotherapy and nanotechnology-based drug delivery systems as a treatment approachVyas, T; Rapalli, VK; Chellappan, DK; Dua, K; Dubey, SK; Singhvi, G
2021-10-15Protein and peptide delivery to lungs by using advanced targeted drug delivery.Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K
2021-10-05Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro.Mehta, M; Malyla, V; Paudel, KR; Chellappan, DK; Hansbro, PM; Oliver, BG; Dua, K
2021-10-01Can dextran-based nanoparticles mitigate inflammatory lung diseases?Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K
2021-09-25Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and CancerDevkota, HP; Adhikari-Devkota, A; Paudel, KR; Panth, N; Chellappan, DK; Hansbro, P; Dua, K; Jafari, SM; Nabavi, SM; Silva, AS
2021-09-13A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations.Joshi, D; Sharma, I; Gupta, S; Singh, TG; Dhiman, S; Prashar, A; Gulati, M; Kumar, B; Vishwas, S; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Negi, P; Dua, K; Singh, SK
2021-09Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspectiveChan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K
2021-09Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospectsGulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H
2021-08A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnosticsAnand, K; Vadivalagan, C; Joseph, JS; Singh, SK; Gulati, M; Shahbaaz, M; Abdellattif, MH; Prasher, P; Gupta, G; Chellappan, DK; Dua, K
2021-08Overview of key molecular and pharmacological targets for diabetes and associated diseasesShahcheraghi, SH; Aljabali, AAA; Al Zoubi, MS; Mishra, V; Charbe, NB; Haggag, YA; Shrivastava, G; Almutary, AG; Alnuqaydan, AM; Barh, D; Dua, K; Chellappan, DK; Gupta, G; Lotfi, M; Serrano-Aroca, Á; Bahar, B; Mishra, YK; Takayama, K; Panda, PK; Bakshi, HA; Tambuwala, MM
2021-08Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseasesShastri, MD; Allam, VSRR; Shukla, SD; Jha, NK; Paudel, KR; Peterson, GM; Patel, RP; Hansbro, PM; Chellappan, DK; Dua, K
2021-08Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseasesMehta, M; Paudel, KR; Shukla, SD; Allam, VSRR; Kannaujiya, VK; Panth, N; Das, A; Parihar, VK; Chakraborty, A; Ali, MK; Jha, NK; Xenaki, D; Su, QP; Wich, PR; Adams, J; Hansbro, PM; Chellappan, DK; Oliver, BGG; Dua, K
2021-08Development of mushroom polysaccharide and probiotics based solid self-nanoemulsifying drug delivery system loaded with curcumin and quercetin to improve their dissolution rate and permeability: State of the artKhursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Jain, SK; Gowthamarajan, K; Zacconi, F; Chellappan, DK; Gupta, G; Jha, NK; Gupta, PK; Dua, K
2021-07-01Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19Jeyaraman, M; Muthu, S; Bapat, A; Jain, R; ES, S; Gulati, A; Channaiah Anudeep, T; Dilip, SJ; Jha, NK; Kumar, D; Kesari, KK; Ojha, S; Dholpuria, S; Gupta, G; Dureja, H; Chellappan, DK; Singh, SK; Dua, K; Jha, SK